Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Breast Cancer Prediction Using Machine Learning Algorithms.
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: NAGABABU GARIGIPATI
ISBN: 9786206686521
Год издания: 1905
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 68
Издательство: LAP LAMBERT Academic Publishing
Цена: 27379 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: Breast cancer is the most common type of cancer in women. When cancers are found early, they can often be cured. There are some devices that detect the breast cancer but many times they lead to false positives, which results in patients undergoing painful, expensive surgeries that were not even necessary. These type of cancers are called benign which do not require surgeries and we can reduce these unnecessary surgeries by using Machine Learning. We take a dataset of the previous breast cancer patients and train the model to predict whether the cancer is benign or malignant. The objective of these predictions is to assign patients to either a benign group that is noncancerous or a malignant group that is cancerous. These predictions will help doctors to do surgeries only when the cancer is malignant, thus reducing the unnecessary surgeries for woman.
Ключевые слова: Breast Cancer Prediction, Machine Learning, k-nearest neighbor(KNN), Support Vector Machine(SVM)
Похожие издания
Отрасли знаний: Естественные науки -> Биология -> Биохимия Wafaa Shousha,El-Sayed Mahdy and Shaymaa Shawky New approaches for prediction of breast cancer. Prediction of breast cancer. 2013 г., 192 стр., мягкий переплет Biomarkers accepted for clinical use in breast cancer, such as CA 15-3 and CEA have low sensitivity and specificity, and are thus more useful for patients at an advanced stage of breast cancer rather than for early cancer diagnosis. So, there is a need for new biomarkers to help in diagnosis of primary breast cancer and this is one of the aims of... | 46579 тг |